Med Safety, a free smartphone app, has boosted healthcare workers’ reporting of adverse drug reactions in Uganda.

To reflect this reality, the Gladstone Institute of Virology has taken on a new name: the Gladstone Infectious Disease ...

New study findings could change treatments for HIV in young children. HIV remission may be possible for very young children ...

A total of 10 individuals with HIV have been cured to date. Most of these patients have remained anonymous, but three have ...

The number of people living with HIV in Bulawayo has declined from 79 711 in 2020 to 76 608 in 2024, as new infections continue to fall in response to significant progress in prevention and treatment.

The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir ...

Research published in The Lancet HIV earlier this year, experts estimated that, if purchased at scale, the cost of generic lenacapavir could range from USD 35 to USD 46 per person-year. Falling to USD ...

Yeztugo (lenacapavir) is an HIV-1 capsid inhibitor that is administered every 6 months after an initial dosing regimen.

Scientists say the drug stops the virus from replicating inside cells. The landmark deal to provide cheaper antiretroviral ...

A coalition of leading infectious disease and cancer experts is urging for the creation of a clinical trials network to ...

Globally, over half of people living with HIV are women. But in clinical cure trials, they make up only about 20% of ...